Charles Williams
Director of Finance/CFO chez SURROZEN, INC.
Fortune : 23 157 $ au 31/03/2024
Profil
Charles Williams is currently the Chief Operating & Financial Officer at Surrozen, Inc. He previously worked as the Director-Corporate & Business Development at MAP Pharmaceuticals LLC from 2008 to 2013, and as the Head-Corporate Development at Jazz Pharmaceuticals Plc from 2013 to 2020.
Mr. Williams completed his undergraduate degree at Cornell University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SURROZEN INC
0,07% | 04/04/2024 | 1 474 ( 0,07% ) | 23 157 $ | 31/03/2024 |
Postes actifs de Charles Williams
| Sociétés | Poste | Début |
|---|---|---|
| SURROZEN, INC. | Director of Finance/CFO | 01/11/2020 |
Anciens postes connus de Charles Williams
| Sociétés | Poste | Fin |
|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | 01/11/2020 |
MAP Pharmaceuticals LLC
 MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Corporate Officer/Principal | 01/01/2013 |
Formation de Charles Williams
| Cornell University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| SURROZEN, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Health Technology |
